Michael L. Alosco, PhD

Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Dr. Alosco is a licensed clinical neuropsychologist and serves as the co-director of the Boston University Alzheimer’s Disease Research Center Clinical Core and is a lead investigator of the BU CTE Center. He also oversees Neuropsychology for the Memory and Aging Clinic at Boston Medical Center. He completed his undergraduate studies at Providence College and he earned his doctoral degree in clinical psychology, with a focus on neuropsychology, in 2015 from Kent State University. He completed his clinical internship in neuropsychology at the VA Boston Healthcare System. Dr. Alosco completed his post-doctoral studies in neuropsychology via NIH-funded training Awards (T32, F32) at the Boston University Alzheimer’s Disease Research Center and CTE Center. In 2018, he became an Assistant Professor of Neurology at the Chobanian and Avedisian School of Medicine and he was promoted to Associate Professor in 2019. Dr. Alosco has >150 peer-reviewed publications, is the PI of multiple NIH funded grants, is the recipient of an NIH/NINDS K23 Award, is the Project Lead of an NIH-funded multisite U54 grant, and serves as aco-investigator on numerous federal and non-federal funded grants. He has also written numerous book chapters, and he is the co-Editor of the Oxford Handbook of Adult Cognitive Disorders which was published by Oxford University Press in 2019.

Dr. Alosco has an active and established research program that has a thematic focus on three areas: (1) the relationship between repetitive head impacts (RHI) and traumatic brain injury (TBI) with a later-life cognitive and neuropsychiatric decline, as well as neurodegenerative disease(s); (2) the contribution of cerebrovascular disease to the clinical and neuropathological expression of CTE, AD, and AD-related dementias (ADRD); and (3) in vivo biomarker development for CTE, AD, and ADRD with a focus on tau PET imaging, structural MRI, and blood-based biomarkers.

Publications

  • Published 8/3/2026

    Kropp E, Varkanitsa M, Stein TD, Turk K, Alosco ML, Tripodis Y, Romero JR, Kiran S, Budson AE, Charidimou A. Diagnostic Accuracy of the Boston Criteria v2.0 in Memory Clinic Patients: An MRI-Neuropathology Validation Study. Neurology. 2026 Aug 25; 107(4):e218314. PMID: 42546232.

    Read at: PubMed

  • Published 7/11/2026

    Mulayi SC, Aaronson A, Goostrey KJ, Tuz-Zahra F, Tripodis Y, Cole-French WS, Roebuck M, Schneider G, Pine BN, Palmisano JN, Martin BM, Zavitz KH, Katz DI, Nowinski CJ, McKee AC, Stein TD, Mackin RS, McClean MD, Weuve J, Mez J, Weiner MW, Nosheny RL, Alosco ML, Stern RA. Cognitive and Behavioral Functioning in Female Former Soccer Players: Results from the Head Impact and Trauma Surveillance Study (HITSS). medRxiv. 2026 Jul 11. PMID: 42465948.

    Read at: PubMed

  • Published 7/8/2026

    Luster CB, Abdolmohammadi B, Mastrodicasa MJ, Nowinski CJ, Feigel ED, Finegan B, White AJ, Connors EJ, Rovito CA, Zafonte RD, Alosco ML, McKee AC, Mez J, Daneshvar DH. Neurodegenerative mortality among National Football League Players. EClinicalMedicine. 2026 Jul; 97:104051. PMID: 42534468.

    Read at: PubMed

  • Published 7/1/2026

    Miner AE, Zetterberg H, Blennow K, Groh JR, Singh A, Dieckhoff K, Tripodis Y, Adler CH, Balcer LJ, Bernick C, Peskind E, Asken BM, Tanner JA, Rabinovici GD, Banks SJ, Barr WB, Wethe JV, Cantu RC, Dodick DW, Mez J, Palmisano JN, Martin B, Stein TD, McKee AC, Cummings JL, Shenton ME, Reiman EM, Stern RA, Ashton NJ, Alosco ML. Plasma Phosphorylated Tau 217 in Participants at Risk for Chronic Traumatic Encephalopathy. JAMA Netw Open. 2026 Jul 01; 9(7):e2622966. PMID: 42440317.

    Read at: PubMed

  • Published 6/23/2026

    Aaronson A, Ly MT, Tripodis Y, Altaras C, Lenio S, Farris CW, Nowinski CJ, O'Connor MK, Martin BM, Palmisano JN, Nosheny RL, Gifford KA, Steinberg EG, Turk KW, Budson AE, Stein TD, McKee AC, Mez J, Alosco ML. Subjective cognitive complaints and decline among aging individuals with prior repetitive head impact exposure. Alzheimers Dement (Amst). 2026; 18(2):e70407. PMID: 42358563.

    Read at: PubMed

Education

  • Kent State University, PhD
  • Kent State University, MA
  • Providence College, BA